A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease

Smits, B. M.; Lelieveld, P. H.C.; Ververs, F. A.; Turkenburg, M.; de Koning, C.; van Dijk, M.; Leavis, H. L.; Boelens, J. J.; Lindemans, C. A.; Bloem, A. C.; van de Corput, L.; van Montfrans, J.; Nierkens, S.; van Gijn, M. E.; Geerke, D. P.; Waterham, H. R.; Koenderman, L.; Boes, M.

doi:https://doi.org/10.1016/j.clim.2019.108248

A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease

DSpace/Manakin Repository

A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease

Smits, B. M.; Lelieveld, P. H.C.; Ververs, F. A.; Turkenburg, M.; de Koning, C.; van Dijk, M.; Leavis, H. L.; Boelens, J. J.; Lindemans, C. A.; Bloem, A. C.; van de Corput, L.; van Montfrans, J.; Nierkens, S.; van Gijn, M. E.; Geerke, D. P.; Waterham, H. R.; Koenderman, L.; Boes, M.

(2020) Clinical Immunology, volume 212

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Immunology and Allergy, Immunology, Letter

DOI: https://doi.org/10.1016/j.clim.2019.108248

ISSN: 1521-6616

Publisher: Academic Press Inc.

Note: Funding Information: We thank Ninke Nieuwenhuis and Willemien Zuilhof for discussions on and reviewing of previous studies on RAC2-GAP interactions. We also would like to thank our patients for providing us with the information and samples needed to perform this study. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

(Peer reviewed)